youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
CYTK:NASDAQ
Cytokinetics, Inc.
$62.03
arrow_downward
-1.52%(-0.96) 1D
$62.03
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$63.40
High
$64.00
Low
$61.96
Mkt. cap
8.62B
Avg. vol.
1.85M
Volume
1.56M
52-wk high
$88.31
52-wk low
$58.05
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
Open
$63.40
High
$64.00
Low
$61.96
Mkt. cap
8.62B
Avg. vol.
1.85M
Volume
1.56M
52-wk high
$88.31
52-wk low
$58.05
EPS
-$7.22
Beta
0.41
Shares outstanding
139.02M
No. of employees
673
News stories
From web sources and news partners
Investing.com
·
4 hours ago
Cytokinetics CEO Robert Blum sells $471,075 in CYTK stock
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytokinetics.com